Cinacalcet, FGF23, and Cardiovascular Disease in Hemodialysis | Journal Scan

Study Questions:

What are the effects of the calcimimetic cinacalcet (vs. placebo) on reducing serum FGF23, and are changes in FGF23 associated with death and cardiovascular events?